Australian-Singaporean company Osteopore Limited has launched a Clinical Centre of Excellence (CCoE) in Singapore, focusing on medial wedge opening high tibial osteotomy (MOWHTO). This initiative, in collaboration with Total Orthopaedic Care & Surgery and led by Dr Hamid Razak, aims to enhance orthopaedic care and improve patient outcomes in knee preservation.
The CCoE will serve as a training hub, offering educational sessions on MOWHTO techniques and post-surgery rehabilitation. Dr Hamid, a consultant orthopaedic surgeon with over 15 years of experience, will lead these efforts. He is also an Adjunct Associate Professor at Duke-NUS Medical School and a key opinion leader on Osteopore’s clinical advisory board.
MOWHTO is gaining traction globally as it offers joint preservation and minimal trauma, delaying the need for total knee arthroplasty. Recent studies highlight advancements in surgical strategies that improve patient outcomes. Osteopore’s MOWHTO product has outperformed allogeneic femoral head grafts in bone union in clinical studies.
The MOWHTO market is projected to grow at a compound annual growth rate of 9.2%, with procedures expected to reach 35,000 annually in the Asia Pacific region by 2025. Osteopore CEO Dr Lim Yujing emphasised the importance of training and education in using innovative products with appropriate surgical techniques. Dr Hamid expressed his commitment to advancing knee preservation through collaborative research and innovation.
This new centre underscores Osteopore’s dedication to advancing orthopaedic care and highlights the growing trend in knee preservation techniques.
“`
This news story was carefully selected and published by a human editor, though the content itself was AI-generated. If you spot an error, please report it here.
